26 year-old male dies of myocarditis four days after receiving his third booster shot

According to the autopsy report and death certificate obtained by the Defender, for this 26-year-old male "post-Pfizer Covid vaccination myocarditis has been identified to cause left ventricular dysfunction” that led to his death. 

At birth, he was diagnosed with a rare type of blood vessel abnormality inside the brain called Vein of Galen Malformation. This condition could be caused by mutations in RASA1 gene - involved in numerous physiological processes such as angiogenesis, cell proliferation, and apoptosis; regulator of immune B cells TGF-β and EPHB4 involved in cell migration.  He had 13 brain surgeries, endless MRIs, CAT scans, angiograms, pokes, and a final radiation treatment that was a success in eliminating the arteriovenous malformation (AVM).

He got his first and second doses of Pfizer vaccine as soon as his age group was eligible. He did not have any side effects. Almost 7 months later he received his third shot of BNT162b2 vaccine (batch FE3590). It caused some muscle soreness and fatigue. On the fourth day he developed a sore throat. He was feverish and had elevated heart rate. Since this was considered normal according to CDC guidelines no measures - other than Tylenol - were taken. He died in his chair 2 hours after a dinner. Apple watch data show that his heart rate was very high at first, but dropped into the 60s, which was low compared to usual 80s and 90s — and then it just stopped.


Exclusive: Autopsy Confirms 26-Year-Old’s Death From Myocarditis Directly Caused by Pfizer COVID Vaccine • Children's Health Defense (childrenshealthdefense.org)

Autopsy Reveals Death of 26-Year-Old Man Who Developed Myocarditis was Due to Pfizer Vaccine – DC Weekly

Joseph-G-Keating-age-26-death-certificate-scaled.jpg (1920×2560) (childrenshealthdefense.org)


Popular posts from this blog

A New Onset of Ulcerative Colitis post-2nd-breakthrough-COVID-19

Navigating the Tripledemic: JN.1, RSV, and Flu Update

The offshoots of JN.1 in the Evolutionary Trajectory of COVID-19